Astrana Health (ASTH) vs Robert Half (RHI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Astrana Health (ASTH) has outperformed Robert Half (RHI) over the past year, gaining 16.7% versus a gain of 1.3%. Over five years, ASTH leads with a -49.8% price change compared with -68.7% for RHI. Robert Half is the larger company by market cap ($3.50 billion vs $1.86 billion), about 1.9 times the size, while Astrana Health is growing revenue faster (+56.4% vs -7.2%).
On valuation, Astrana Health trades at a lower forward P/E (10.3x vs 17.4x for Robert Half). Robert Half pays a dividend yielding 6.90%, while Astrana Health does not currently pay one. Robert Half converts more of its revenue into profit, with a net margin of 2.5% versus 0.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | RHI |
|---|---|---|
| Share price | $37.49 | $34.20 |
| Market cap | $1.86B | $3.50B |
| 1-day change | +4.50% | +0.28% |
| YTD return | +44.58% | +25.55% |
| 1-year return | +16.73% | +1.28% |
| 5-year return | -49.83% | -68.70% |
| P/E ratio (TTM) | 45.16 | 29.73 |
| Forward P/E | 10.31 | 17.38 |
| EPS (TTM) | $0.83 | $1.15 |
| Dividend yield | 0.00% | 6.90% |
| Annual dividend | $0.00 | $2.36 |
| Revenue (latest FY) | $3.18B | $5.38B |
| Revenue growth (YoY) | +56.39% | -7.20% |
| Net income (latest FY) | $22.49M | $132.99M |
| Gross margin | 10.73% | 37.23% |
| Operating margin | 2.47% | 1.42% |
| Net margin | 0.71% | 2.47% |
| 52-week high | $51.60 | $46.70 |
| 52-week low | $18.08 | $21.83 |
| Distance from 52-week high | -27.35% | -26.78% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +37.84% | +2.35% |
| Average volume | 458.61K | 2.14M |
| Shares outstanding | 49.60M | 102.36M |
| Employees | 3,000 | 14,500 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASTH has outperformed RHI by 15.4 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (45.2x vs 29.7x trailing P/E).
- Robert Half offers a meaningfully higher dividend yield (6.90% vs 0.00%).
- Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs -7.20%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About Robert Half
RHI stock →Robert Half Inc. provides talent solutions and business consulting services in the United States and internationally.
Consumer Discretionary · Professional Services · 14,500 employees
ASTH vs RHI FAQ
Which is bigger, Astrana Health or Robert Half?
Robert Half (RHI) is larger, with a market capitalization of $3.50B compared with $1.86B for Astrana Health (ASTH).
Which stock has performed better over the past year, ASTH or RHI?
ASTH returned +16.73% over the past 12 months, compared with +1.28% for RHI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or RHI?
RHI has the lower trailing P/E at 29.7, versus 45.2 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Astrana Health or Robert Half?
Robert Half pays a dividend yielding 6.90%, while Astrana Health does not currently pay a regular dividend.
Are Astrana Health and Robert Half in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.